Sign inJoin waitlistJoin the waitlist

Andrew Hendifar

Medical Director, Pancreatic Cancer · Cedars-Sinai Medical Center

Credentials: · · · ·

History

Pancreatic Cancer · Cedars-Sinai Medical Center
Present
Cedars-Sinai Medical Center
Present
Cedars-Sinai Medical Center
Present

Hematology and Medical Oncology
University of Southern California/Los Angeles General Medical Center
2006–2009
Internal Medicine
University of Southern California/Los Angeles General Medical Center
2003–2006
Tulane University School of Medicine
1999–2003

Research

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
New England Journal of Medicine · 2017 · 2,601 citations
177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term…
The Lancet Oncology · 2021 · 510 citations
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
The Lancet Oncology · 2020 · 455 citations

Jun Gong
76 papers · 14 as a resident
Arsen Osipov
51 papers · 6 as a resident
Nicholas Nissen
41 papers
Richard Tuli
38 papers
Alexandra Gangi
30 papers · 15 as a resident
Simon Lo
23 papers
Stephen Pandol
21 papers
Brent Larson
18 papers
Katelyn Atkins
17 papers · 15 as a resident
Srinivas Gaddam
15 papers
Kevin Waters
14 papers · 4 as a fellow
Michelle Guan
14 papers

Clinical trials

Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)
Principal investigator · Recruiting
Cedars-Sinai Medical Center
2025–2026
Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer
Principal investigator · Unknown · Phase 1, Phase 2
Cantex Pharmaceuticals
2023–2025
A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma
Principal investigator · Active not recruiting · Early phase 1
Andrew Hendifar, MD
2022–2026
Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic Cancer
Principal investigator · Completed
Faeth Therapeutics
2021–2025